BioMedical Strategies LLC helps medical device companies accelerate development, de‑risk commercialization, and navigate complex regulatory and clinical pathways.
With deep experience across clinical research, regulatory strategy, reimbursement, and marketing, we guide innovators from concept through approval and market entry
Dr. Frederick Cahn, Founder & CEO
Dr. Frederick Cahn founded BioMedical Strategies in 2003 in La Jolla, California, to bridge the critical gap between innovative medical technologies and successful market adoption.
During the 2020 COVID epidemic, we moved our office to White River Junction, Vermont. Now, in 2026, we are opening an office in San Francisco, California, to improve our access to this center of medical device and artificial intelligence innovation.
With over three decades in biotechnology, medical devices, and regulatory science, he brings a unique combination of academic rigor and practical business expertise.
Career Highlights
Entrepreneurial Leadership
- Founded and led multiple successful biotechnology ventures
- Sr. VP Technology at Integra LifeSciences, overseeing artificial skin technology commercialization
- Successfully navigated complex FDA approvals, including PMA supplements without clinical holds
Technical Innovation
- Pioneered FTIR chemometrics in analytical chemistry
- Invented weighted porous microcarrier technology for biopharmaceutical manufacturing
- Principal Investigator on NIH and NIST grants in biomaterials and tissue engineering
Clinical & Research Support
- Led successful FDA presentations resulting in product approvals
- Expert in clinical trial design and statistical analysis
- Authored comprehensive physician training programs required by FDA
Industry Recognition
- Member of Industrial Advisory Boards at leading institutions:
- New Jersey Center for Biomaterials and Medical Devices
- University of Washington Engineered Biomaterials Center
- MIT Center for Biomedical Engineering
- UCSD Department of Bioengineering
- Chairman, ASTM International Sub-committee F04.41 (Tissue Engineering Standards)
- Advisor to:
- United States Pharmacopeia
- American Medical Association CTP Editorial Panel
- NIH SBIR Study Sections
La Jolla, Vermont, San Francisco
Academic Foundation
- B.A. Physics and Biology, University of California, Berkeley
- Ph.D., Biophysics, Massachusetts Institute of Technology
- Research Assistant Professor, Dartmouth Medical School in Cellular and Molecular Biology
LinkedIn Profile
https://www.linkedin.com/in/fcahn/